Nutritional supplements firm GNC has reached a deal with the New York State attorney general's office to do more stringent testing of ingredients in its products, including the use of genetic testing. 

In a statement on Monday, GNC emphasizes that all of its relevant products were in compliance with the Food and Drug Administration's "Current Good Manufacturing Practices" and are "safe, pure, properly labeled and in full compliance with all regulatory requirements." 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.